Latest Parkinson Stories
Largest grassroots fundraiser in the U.S.
Data indicated comparable efficacy and safety for extended release and immediate release formulations of pramipexole SEATTLE, April 29 /PRNewswire/ -- New findings from two double-blind studies investigating the efficacy, safety and tolerability of pramipexole dihydrochloride tablets in an extended release, once-daily formulation, for the treatment of Parkinson's disease (PD), are being presented today at the American Academy of Neurology (AAN) 61st Annual Meeting in Seattle. The first...
Stalevo Will Retain Decision Resources' Gold-Standard Status Through 2017 for Parkinson's Disease, According to a New Report from Decision Resources WALTHAM, Mass., April 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a once-daily transdermal formulation of levodopa would earn a 30 percent patient share in Parkinson's disease in both the United States and in Europe, according to surveyed U.S.
First Ever Virtual Parkinson's Unity Walk Launched to Expand Participation and Donations NEW YORK, April 9 /PRNewswire/ -- On Saturday April 25, the Parkinson's disease community will unite in New York City's Central Park for the 15th annual Parkinson's Unity Walk to raise awareness and funds for Parkinson's disease research.
Personal Genetics Company to Assemble Online Community of 10,000 Individuals with PD To Drive New Online Research Platform MOUNTAIN VIEW, Calif., March 12 /PRNewswire/ -- 23andMe, Inc., an industry leader in personal genetics, announced today that it has launched a Parkinson's disease initiative in collaboration with The Parkinson's Institute and Clinical Center ("PI") and The Michael J.
Research and Markets (http://www.researchandmarkets.com/research/c84a4e/forecast_insight) has announced the addition of the "Forecast Insight: Parkinson's Disease - Market Upgrade following Evidence of Disease Slowing with Azilect" report to their offering.
After working on the Manchester Guardian and the Daily Express, he moved into television with Granada working on current affairs and film programmes.
NEW YORK, Oct. 7 /PRNewswire/ -- New findings from the first nationwide survey in a decade to explore the dynamics between neurologists, people with Parkinson's disease and their caregivers, revealed a need for increased education on key issues in the management of Parkinson's disease.
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.
By TOM HOSKYNS Hit & Run... Michael Parkinson, eminence grise of light entertaiment, writes in his new memoirs that he doesn't approve of Simon Cowell - Parky reckons that 'The X Factor' mogul promotes mediocrity in the music industry.